Calumet Completes Upsized Notes Offering
Rhea-AI Summary
Calumet (NASDAQ: CLMT) announced that its subsidiaries completed a private placement of $405 million aggregate principal amount of 9.75% Senior Notes due 2031, issued at 98.996% of par for net proceeds of approximately $393 million. The Offering was upsized from an initial $350 million. Calumet intends to use the net proceeds, cash on hand and revolver borrowings to redeem outstanding 11.00% Senior Notes due 2026 and 8.125% Senior Notes due 2027, eliminating near‑term senior maturities and supporting operations and the Montana Renewables MaxSAF™ 150 expansion.
Positive
- Offering upsized to $405M from $350M
- Net proceeds of approximately $393M
- New notes mature in 2031, eliminating near‑term maturities
- Company cites >$220M restricted debt reduction in 2025 and >$120M cash generated in H2 2025
Negative
- Notes issued at a discount
98.996% of par), reducing cash received versus principal - New 9.75% coupon establishes a long‑term interest obligation through 2031
Key Figures
Market Reality Check
Peers on Argus
CLMT fell 1.29% while key specialty/chemical peers like SCL, ECVT, ODC, and KRO rose between about 0.95% and 1.30%, pointing to a stock-specific reaction to the notes offering rather than a sector-wide move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 07 | Debt placement pricing | Positive | +1.8% | Upsized pricing of <b>$405M</b> 9.75% senior notes due 2031. |
| Jan 06 | Debt placement announcement | Positive | +0.4% | Announced <b>$350M</b> senior notes deal to fund note redemptions. |
| Jan 05 | Preliminary earnings | Neutral | +0.4% | Shared FY 2025 loss range and <b>$285–305M</b> Adjusted EBITDA outlook. |
| Jan 02 | Conference attendance | Neutral | -1.6% | Planned meetings at Goldman Sachs energy conference. |
| Dec 08 | Conference attendance | Neutral | +2.1% | Announcement to attend Wells Fargo energy symposium. |
Recent CLMT headlines, including prior debt placement and preliminary results, mostly saw price moves that aligned directionally with the tone of the news, with one divergence on a conference-attendance update.
Over the past months, Calumet reported preliminary FY 2025 results with a net loss range but solid Adjusted EBITDA and over $220 million restricted debt reduction, aided by a $110 million Royal Purple divestiture and a DOE loan that removed about $80 million of annual cash debt service. It then announced a $350 million senior notes private placement, later upsized to $405 million, to fund redemptions of 11.00% 2026 notes and 8.125% 2027 notes. The current closing of the upsized notes offering executes that refinancing plan and removes near-term maturities highlighted in earlier releases.
Market Pulse Summary
This announcement finalizes an upsized $405 million private placement of 9.75% Senior Notes due 2031, with net proceeds of about $393 million earmarked, along with cash and revolver borrowings, to redeem 11.00% 2026 and 8.125% 2027 notes. It follows earlier 2026 communications on debt reduction and liquidity. Investors monitoring this story may focus on future filings for evidence of sustained cost reductions, cash generation, and progress at Montana Renewables, as well as any updates to debt levels and maturity profiles.
Key Terms
rule 144a regulatory
regulation s regulatory
senior notes financial
revolving credit facility financial
aggregate principal amount financial
forward-looking statements regulatory
AI-generated analysis. Not financial advice.
As previously announced, Calumet intends to use all of the net proceeds from the Offering, together with cash on hand and borrowings under its revolving credit facility, to redeem all of the Issuers' outstanding
"The broad support for this over-subscribed offering was largely a result of over
About Calumet
Calumet, Inc. (NASDAQ: CLMT) manufactures, formulates and markets a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. Calumet is headquartered in
Cautionary Statement Regarding Forward-Looking Statements
Certain statements and information in this press release may constitute "forward-looking statements." The words "will," "may," "intend," "believe," "expect," "outlook," "forecast," "anticipate," "estimate," "continue," "plan," "should," "could," "would," or other similar expressions are intended to identify forward-looking statements, which are generally not historical in nature. The statements discussed in this press release that are not purely historical data are forward-looking statements, including, but not limited to, the statements regarding the use of proceeds from the Offering and the Redemptions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. While our management considers these assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies and uncertainties, most of which are difficult to predict and many of which are beyond our control. Accordingly, our actual results may differ materially from the future performance that we have expressed or forecast in our forward-looking statements. For additional information regarding known material risks, uncertainties and other factors that can affect future results, please see our filings with the Securities and Exchange Commission ("SEC"), including the risk factors and other cautionary statements in the latest Annual Report on Form 10-K of the Company and other filings with the SEC by the Company. We undertake no obligation to publicly update or revise any forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required by applicable law.
View original content:https://www.prnewswire.com/news-releases/calumet-completes-upsized-notes-offering-302658953.html
SOURCE Calumet, Inc.